Islet Management’s GeneDx Holdings Warrant WGSWW Stock Holding History

Islet Management’s Portfolio WGSWW Stock Details WGSWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-208,166	Closed	-$204K	–	205
2021 Q4	$204K	Buy	+208,166	New	+$410K	0.01%	170

Other funds holding WGSWW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

BCP

Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Islet Management's WGSWW Position: Q4 2022 in Review

Islet Management sold out of GeneDx Holdings Warrant (WGSWW) in Q4 2022, closing a stake of 191,109 shares — an estimated $43K sold.

Islet Management first reported a position in WGSWW in Q1 2022 and held it in 3 quarters. The position peaked at $144K in Q1 2022. 26 funds tracked by Wall St. Rank hold WGSWW as of Q4 2022.

Islet Management reported no remaining GeneDx Holdings Warrant position as of Q4 2022 after selling out during the quarter.
Islet Management sold 191,109 GeneDx Holdings Warrant shares in Q4 2022, an estimated $43K.
Islet Management first reported a position in GeneDx Holdings Warrant in Q1 2022 and held it in 3 quarters.
Islet Management's GeneDx Holdings Warrant position peaked at $144K in Q1 2022.
26 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q4 2022.

Based on Islet Management's 13F filing for Q4 2022, filed 14 Feb 2023.